Synlett 2010(6): 979-981  
DOI: 10.1055/s-0029-1219396
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of 3,4-Diarylbenzophenones by Site-Selective Suzuki-Miyaura Reactions of 3,4-Bis(trifluoromethylsulfonyloxy)benzophenone

Muhammad Nawaza, Rasheed Ahmad Kheraa, Imran Malika, Muhammad Farooq Ibada, Obaid-Ur-Rahman Abida, Alexander Villingera, Peter Langer*a,b
a Institut für Chemie, Universität Rostock, Albert Einstein Str. 3a, 18059 Rostock, Germany
b Leibniz-Institut für Katalyse an der Universität Rostock e.V., Albert Einstein Str. 29a, 18059 Rostock, Germany
Fax: +49(381)4986412; e-Mail: peter.langer@uni-rostock.de;
Further Information

Publication History

Received 9 November 2009
Publication Date:
17 February 2010 (online)

Abstract

The Suzuki-Miyaura reaction of the bis(triflate) of 3,4-dihydroxybenzophenone with two equivalents of boronic acids gave 3,4-diarylbenzophenones. The reaction with one equivalent of arylboronic acids resulted in site-selective attack onto carbon atom C-4. 3,4-Diarylbenzophenones containing two different aryl groups were prepared by sequential addition of two different boronic acids.

    References and Notes

  • Cytotoxic activity:
  • 1a De Souza AO. Santos RR. Melo PS. Alderete JB. De Conti R. Haun M. Sato DN. Duran N. Pharmazie  2001,  56:  871 
  • Antibacterial activity:
  • 1b De Souza AO. Alderete JB. Schmidt F. Sato DN. Duran N. Arzneim. Forsch.  1999,  49:  1025 
  • Inhibition of ³H-progesterone binding:
  • 2a Kumar S. Seth M. Bhaduri AP. Agnihotri A. Srivastava AK. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1984,  23:  154 
  • Inhibition of the interleukin (IL-1) biosynthesis:
  • 2b Batt DG. Goodman R. Jones DG. Kerr JS. Mantegna LR. J. Med. Chem.  1993,  36:  1434 
  • Inhibition of the human type-2 steroid 5α-reductase:
  • 2c Holt DA. Yamashita DS. Konialian-Beck AL. Luengo JI. Abell AD. J. Med. Chem.  1995,  38:  13 
  • Inhibition of COX-1:
  • 2d Dannhardt G. Fiebich BL. Schweppenhaeuser J. Eur. J. Med. Chem.  2002,  147 
  • Inhibition of human liver microsomes:
  • 2e Lenhart A. Reinert DJ. Aebi JD. Dehmlow H. Morand OH. Schulz GE. J. Med. Chem.  2003,  46:  2083 
  • 3 Appel B. Rotzoll S. Kranich R. Reinke H. Langer P. Eur. J. Org. Chem.  2006,  3638 
  • 4 Guarnieri A. Burnelli S. Varoli L. Busacchi I. Barbaro AM. Arch. Pharm. (Weinheim, Ger.)  1981,  314:  703 
  • 5 Aburaki S. Okuyama S. Hoshi H. Kamachi H. Nishio M. J. Antibiot.  1993,  46:  1447 
  • 6a Pettit GR. Toki B. Herald DL. Verdier-Pinard P. Boyd MR. Hamel E. Pettit RK. J. Med. Chem.  1998,  41:  1688 
  • 6b Liou J.-P. Chang J.-Y. Chang C.-W. Chang C.-Y. Mahindroo N. Kuo F.-M. Hsieh H.-P. J. Med. Chem.  2004,  47:  2897 
  • 6c Liou J.-P. Chang C.-W. Song JS. Yang YS. Yeh CF. Tseng HY. Lo YK. Chang C.-L. Chang C.-M. Hsieh H.-P. J. Med. Chem.  2002,  45:  2556 
  • 7a Cai X. Sakamoto M. Fujitsuka M. Majima T. Chem. Eur. J.  2005,  11:  6471 ; and references cited therein
  • 7b Langhals H. Fuchs K. Chem. Unserer Zeit  2004,  38:  98 ; and references cited therein
  • 8 Buchta E. Egger H. Chem. Ber.  1957,  90:  2760 
  • 9 Shiue J.-S. Lin M.-H. Fang J.-M. J. Org. Chem.  1997,  62:  4643 
  • 10 For a review of site-selective palladium(0)-catalyzed cross-coupling reactions, see: Schröter S. Stock C. Bach T. Tetrahedron  2005,  61:  2245 
  • 11 Nawaz M. Adeel M. Farooq M. Langer P. Synlett  2009,  2154 
12

3,4-Bis(trifluoromethylsulfonyloxy)benzophenone (2) To a CH2Cl2 solution (10 mL/mmol) of 1 (1.0 equiv) was added pyridine (4.0 equiv) at -78 ˚C under argon atmo-sphere. After 10 min, Tf2O (2.4 equiv) was added at
-78 ˚C. The mixture was allowed to warm to 0 ˚C during 4 h with stirring. The reaction mixture was filtered, and the filtrate was concentrated in vacuo. The product was isolated by rapid column chromatography (flash silica gel, heptanes-EtOAc). Starting with 1 (214 mg, 1.0 mmol), pyridine (0.32 mL, 4.0 mmol), and Tf2O (0.38 mL, 2.4 mmol), 2 was isolated as a highly viscous oil (401 mg, 84%). ¹H NMR (300 MHz, CDCl3): δ = 7.44-7.60 (m, 5 H, ArH), 7.68-7.74 (m, 2 H, ArH), 7.86 (s, 1 H, ArH). ¹³C NMR (62.89 MHz, CDCl3): δ = 115.9 (q, J F,C = 320.0 Hz, CF3), 121.1 (q, J F,C = 321.3 Hz, CF3), 123.6, 125.2, 128.7, 129.9, 130.9, 133.6 (CH), 135.7, 138.7, 140.2, 142.9 (C), 192.6 (C=O). ¹9F NMR (282 MHz, CDCl3): δ = -73.3, 72.0 (2 CF). IR (KBr): ν = 3061, (w), 1598, 1589, 1580 (m), 1496, 1431, 1414, 1319, 1291 (m), 1265 (s), 1165, 1077, 1028, 989, 976, 932 (m), 887, 787, 757 (s), 680, 595, 572 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 478 (74) [M+], 401 (5), 345 (08), 253 (26), 225 (32), 204 (04), 167 (22), 156 (06), 128 (27), 105 (100), 77 (43), 69 (30), 51 (14). HRMS (EI, 70 eV): m/z calcd for C15H8F6O7S2 [M+]: 477.96101; found: 477.960958.

13

General Procedure for the Synthesis of 4a-i, 5a-e, and 6a-d
The reaction was carried out in a pressure tube. To a dioxane suspension (5 mL) of 2 or 5, Pd(PPh3)4, arylboronic acid, and K3PO4 were added. The mixture was stirred at 110 ˚C under argon atmosphere for the indicated period of time (6-8 h). The reaction mixture was diluted with H2O and extracted with CH2Cl2 (3 × 25 mL). The combined organic layers were dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue was purified by flash chromatography (silica gel, EtOAc-heptanes).

14

3,4-Bis(3,5-dimethylphenyl)benzophenone (4c) Starting with 2 (220 mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 3,5-dimethylphenylboronic acid (180 mg, 1.2 mmol), and 1,4-dioxane (5 mL per mmol of 2), 4c was isolated as a crystalline solid (134 mg, 75%); mp 140-142 ˚C. ¹H NMR (250 MHz, CDCl3): δ = 2.09 (s, 6 H, 2 CH3), 2.11 (s, 6 H, 2 CH3), 6.67-6.77 (m, 5 H, ArH), 7.38-7.48 (m, 5 H, ArH), 7.68-7.78 (m, 4 H, ArH). ¹³C NMR (75.46 MHz, CDCl3): δ = 21.2 (2 CH3), 21.3 (2 CH3), 125.1, 127.5, 127.7, 128.3, 128.6, 128.8, 130.0, 130.4, 132.1, 132.3 (CH), 136.3, 137.1, 137.2, 137.8, 140.4, 140.5, 140.9, 144.9 (C), 196.4 (C=O). IR (KBr): ν = 3289, 3013, 2916, 2857, 2732 (w), 1732, (s), 1574 1505 (m), 1495, 1455, 1436, 1386, 1328, 1296 (m), 1250 (s), 1199, 1118, 1067, 1036, 959, 902 (m), 882, 842, 793, 738 (s), 695, 648, 596, 567 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 390 (100) [M+], 313 (29), 270 (13), 239 (7), 148 (4), 105 (22), 77 (11). HRMS (EI): m/z calcd for C29H26O [M+]: 390.19782; found: 390.197629.

15

CCDC-759141 contains all crystallographic details of
this publication and is available free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html or can be ordered from the following address: Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB21EZ, UK; fax: +44 (1223)336033; or deposit@ccdc.cam.ac.uk.

16

4-(3,4,5-Trimethoxyphenyl)-3-(trifluorosulfonyloxy)-benzophenone (5d) Starting with 2 (220 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 (3 mol%), 3,4,5-trimethoxyphenylboronic acid (125 mg, 0.59 mmol), and 1,4-dioxane (5mL per mmol of triflate), 5d was isolated as a viscous oil (173 mg, 76%); mp 139-140 ˚C. ¹H NMR (300 MHz, CDCl3): δ = 3.82 (s, 6 H, 2 OCH3), 3.83 (s, 3 H, OCH3), 6.62 (s, 2 H, ArH), 7.39-7.47 (m, 3 H, ArH), 7.56 (s, 1 H, ArH), 7.68-7.78 (m, 3 H, ArH), 7.88 (d, 1 H, J = 6.4 Hz, ArH). ¹³C NMR (75.47 MHz, CDCl3): δ = 56.2 (2 OCH3), 61.0 (OCH3), 106.8 (CH), 120 (q, J F,C = 320 Hz, CF3), 122.0, 128.5, 130.0, 130.4, 133.1, 133.3 (CH), 135.8, 136.7, 137.7, 138.6, 149.0, 153.3 (C), 194.8 (C=O). ¹9F NMR (282 MHz, CDCl3): δ = -73.8 (CF3). IR (KBr): ν = 3065, 2999, 2936 (w), 1660, 1609 (s),1584, 1514, 1488 (m), 1463, 1418, 1393, 1317, 1291, 1278 (m), 1241 (s), 1170, 1104, 1063, 1001, 978 (m), 889, 831, 790, 745 (s), 675, 630, 598, 569 (m) cm. GC-MS (EI, 70 eV):
m/z (%) = 496 (92) [M+], 363 (26), 332 (100), 317 (17), 255 (12), 227 (07), 185 (05), 105 (57), 77 (19). HRMS (EI): m/z calcd for C23H19F3O7S [M+]: 496.07981; found: 496.079887.